Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 July 2005, Vol. 106, No. 2, pp. 681-689.
Prepublished online as a Blood First Edition Paper on April 7, 2005; DOI 10.1182/blood-2004-10-4073.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
2004-10-4073v1
106/2/681    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fält, S.
Right arrow Articles by Wennborg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fält, S.
Right arrow Articles by Wennborg, A.
Related Collections
Right arrow Neoplasia
Right arrow Cell Cycle
Right arrow Signal Transduction
Right arrow Gene Expression
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia

Susann Fält, Mats Merup, Gerard Tobin, Ulf Thunberg, Gösta Gahrton, Richard Rosenquist, and Anders Wennborg

From the Unit of Environmental Medicine, Center for Nutrition and Toxicology, Department of Biosciences at Novum, Karolinska Institutet, Huddinge, Sweden; Department of Hematology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Department of Genetics and Pathology, Uppsala University, Sweden; and Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Sweden.

The usage of the immunoglobulin (Ig) VH3-21 gene is associated with poor prognosis in B-cell chronic lymphocytic leukemia (B-CLL) despite VH gene mutation status. Many VH3-21+ patients also display restricted heavy- and light-chain Ig gene rearrangements, implying a role of antigen selection in disease development. To explore the specific phenotypic/genotypic features among VH3-21+ B-CLLs, we compared gene expression patterns in 15 VH3-21+ and 24 non-VH3-21 patients (11 with unmutated and 13 with mutated VH genes) using Affymetrix microarray analysis (~12 500 genes). A distinct expression profile was identified for VH3-21+ patients in contrast to the Ig-unmutated and -mutated groups. By applying different algorithms, the data enabled an efficient class discrimination of the VH3-21+ subset based on 27 or 57 genes. A set of genes was sorted out which, using different analytical methods, consistently gave a distinction between VH3-21+ and non-VH3-21 samples. Several of these genes are involved in regulation of DNA replication/cell-cycle control, transcription and protein kinase activity, which may render the VH3-21+ cells with a higher proliferative drive. However, no clear evidence of increased B-cell receptor signaling was found in the VH3-21+ group. Altogether, our identification of a specific VH3-21 profile may provide insights into the pathogenesis of the VH3-21+ subgroup. (Blood. 2005;106:681-689)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
E. M. Ghia, S. Jain, G. F. Widhopf II, L. Z. Rassenti, M. J. Keating, W. G. Wierda, J. G. Gribben, J. R. Brown, K. R. Rai, J. C. Byrd, et al.
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection
Blood, May 15, 2008; 111(10): 5101 - 5108.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Bomben, M. Dal Bo, D. Capello, D. Benedetti, D. Marconi, A. Zucchetto, F. Forconi, R. Maffei, E. M. Ghia, L. Laurenti, et al.
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study
Blood, April 1, 2007; 109(7): 2989 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Thorselius, A. Krober, F. Murray, U. Thunberg, G. Tobin, A. Buhler, D. Kienle, E. Albesiano, R. Maffei, L.-P. Dao-Ung, et al.
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status
Blood, April 1, 2006; 107(7): 2889 - 2894.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Kienle, A. Benner, A. Krober, D. Winkler, D. Mertens, A. Buhler, T. Seiler, U. Jager, P. Lichter, H. Dohner, et al.
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes
Blood, March 1, 2006; 107(5): 2090 - 2093.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020